Familial Hypercholesterolemia: Drugs

Department of Health written question – answered on 3rd July 2015.

Alert me about debates like this

Photo of Kevan Jones Kevan Jones Shadow Minister (Defence)

To ask the Secretary of State for Health, when NHS England will issue a commissioning position on the use of Lomitapide for the treatment of Homozygous Familial Hypercholesterolemia; and if he will make a statement.

Photo of George Freeman George Freeman The Parliamentary Under-Secretary of State for Business, Innovation and Skills, The Parliamentary Under-Secretary of State for Health

NHS England is reviewing a number of interventions that will be considered for commissioning from April 2016. Lomitapide for homozygous familial hypercholesterolemia is one of those interventions being considered.

Services for patients with homozygous familial hypercholesterolaemia have become NHS England’s direct commissioning responsibility since 1 April 2015.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.